A multicenter,randomized,controlled clinical trial of early vitrectomy for diffuse diabetic macular edema.
Not Applicable
- Conditions
- diffuse diabetic macular edema
- Registration Number
- JPRN-UMIN000008957
- Lead Sponsor
- Kagoshima University Graduate School of Medical and Dental Science
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 162
Inclusion Criteria
Not provided
Exclusion Criteria
Eyes of signs of vitreomacular traction on biomicroscopy or OCT. Eyes with active proliferative DR. Eyes with known a history of glaucoma,optic nerve atrophy,vitrectomy,intravitreal injection,subtenon injection. Eyes with known a history of photocoagulation within 3 months,cataract operation within 6 months. Patients with any of serious heart disease, cerebrovascular disease,blood disorder, renal failure, malignant tumor, systemic steroids. Patients with HbA1c 10% or higher, or systolic blood pressure of more than 180 mmHg or diastolic blood pressure more than 110 mmHg. Patients with known as steroid responder.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method visual acuity central macular thickness
- Secondary Outcome Measures
Name Time Method